Last reviewed · How we verify

NCT06263556

Effectiveness of TTNS in MS Patients With Lower Urinary Track Symptoms

Status unknown NA Last updated 16 February 2024
What this trial tests

NA trial testing Pelvic floor exercises in Multiple Sclerosis in 64 participants. Status unknown.

Timeline
17 January 2024
Primary endpoint
5 November 2024
5 December 2024

Quick facts

Lead sponsorBakirkoy Dr. Sadi Konuk Research and Training Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment64
Start date17 January 2024
Primary completion5 November 2024
Estimated completion5 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Who can join

Adults 18 to 50, any sex, with Multiple Sclerosis or Lower Urinary Tract Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system. It is characterized with demyelinated plaques affecting subcortical, brain stem, and spinal cord nerve fibers. During the course of the disease, with the affection myelinated nerve tracks, lower urinary track symptoms may occur. 50-90% of the MS patients experience lower urinary track symptoms (LUTS) such as urinary incontinence, urgency, nocturia and/or urinary frequency during the at one point of their life. Aim of this study is to determine the effects of transcutaneous tibial nerve stimulation (TTNS) on symptoms and quality of life in MS patients with LUTS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pelvic floor exercises

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Bakirkoy Dr. Sadi Konuk Research and Training Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06263556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing